SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Linnea Burman, SVP and president of Medtronic Neurovascular, discusses the Scientia Vascular acquisition...
Ferdinand Hui, MD, discusses the endovascular treatment of cerebral venous disorders, a potentially vast...
SmartTRAK highlights three neurointerventional trends to watch in 2026. SmartTRAK highlights recent news...
Raul Nogueira, MD, discusses the latest research and innovation in super-bore catheters for the treatmen...
Stewart Strong, Q’Apel Medical’s recently appointed CEO, discusses the company, his priorities and plans...
SmartTRAK is excited to attend the Society of Neurointerventional Surgery’s (SNIS) 22nd Annual Meeting &...
Scientia Vascular CEO Rick Randall discusses the company, its novel technology and plans for growth in a...
Q’Apel Medical CEO Jodie Fam discusses the company, strategies for growth and Q’Apel’s approach to innov...
SmartTRAK reports on the latest research and innovation in neurointervention from ESMINT 2024. The Europ...
SmartTRAK's Anne Staylor, VP & GM Neuro Therapies, will be attending ESMINT 2024 SmartTRAK is excite...
Login